Header Logo

Search Results (483)

MatchTypeWhy
Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.Academic Article Why?
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?Academic Article Why?
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels.Academic Article Why?
Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics.Academic Article Why?
Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications.Academic Article Why?
Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis.Academic Article Why?
Trends and outcomes associated with angiotensin-converting enzyme inhibitors.Academic Article Why?
The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.Academic Article Why?
Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.Academic Article Why?
Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.Academic Article Why?
Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure?Academic Article Why?
Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure.Academic Article Why?
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.Academic Article Why?
Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.Academic Article Why?
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.Academic Article Why?
Per Page    Page  of 33last Nextnext
Prev
Search Criteria
  • Enzyme Inhibitors
Filter by Type
_
Click "Why?" to see why an item matched the search.